Clinicopathologic and Immunohistochemical Correlates of CTNNB1 Mutated Endometrial Carcinoma

被引：0
|
作者：
Costigan, Danielle C. [1 ,2 ]
Dong, Fei [1 ]
Nucci, Marisa [1 ]
Howitt, Brooke E. [1 ]
机构：
[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
来源：
LABORATORY INVESTIGATION | 2018年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1158
引用
收藏
页码：414 / 415
页数：2
相关论文
共 50 条
  • [41] Intranodal Palisaded Myofibroblastoma: Another Mesenchymal Neoplasm With CTNNB1 (β-catenin Gene) Mutations Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 18 Cases
    Laskin, William B.
    Lasota, Jerzy P.
    Fetsch, John F.
    Felisiak-Golabek, Anna
    Wang, Zeng-Feng
    Miettinen, Markku
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (02) : 197 - 205
  • [42] Rare histologic transformation of a CTNNB1 (β-catenin) mutated prostate cancer with aggressive clinical course
    Akhoundova, Dilara
    Fischer, Stefanie
    Triscott, Joanna
    Lehner, Marika
    Thienger, Phillip
    Maletti, Sina
    Jacquet, Muriel
    Lubis, Dinda S. H.
    Bubendorf, Lukas
    Jochum, Wolfram
    Rubin, Mark A.
    DIAGNOSTIC PATHOLOGY, 2024, 19 (01)
  • [43] Response to: An immunohistochemical approach to detect oncogenic CTNNB1 mutations in primary neoplastic tissues
    Dubbink, Hendrikus J.
    Lavrijsen, Marla
    van den Bosch, Thierry P. P.
    Smits, Ron
    LABORATORY INVESTIGATION, 2019, 99 (03) : 445 - 446
  • [44] CTNNB1 (Beta Catenin) Mutation Identifies Patients with Grades 1 or 2 Endometrioid-Type Endometrial Carcinoma at Risk of Recurrence
    Kurnit, Katherine
    Fellman, Bryan
    Urbauer, Diana
    Mills, Gordon
    Broaddus, Russell
    LABORATORY INVESTIGATION, 2016, 96 : 292A - 293A
  • [45] CTNNB1 (Beta Catenin) Mutation Identifies Patients with Grades 1 or 2 Endometrioid-Type Endometrial Carcinoma at Risk of Recurrence
    Kurnit, Katherine
    Fellman, Bryan
    Urbauer, Diana
    Mills, Gordon
    Broaddus, Russell
    MODERN PATHOLOGY, 2016, 29 : 292A - 293A
  • [46] Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles
    McConechy, Melissa K.
    Ding, Jiarui
    Senz, Janine
    Yang, Winnie
    Melnyk, Nataliya
    Tone, Alicia A.
    Prentice, Leah M.
    Wiegand, Kimberly C.
    McAlpine, Jessica N.
    Shah, Sohrab P.
    Lee, Cheng-Han
    Goodfellow, Paul J.
    Gilks, C. Blake
    Huntsman, David G.
    MODERN PATHOLOGY, 2014, 27 (01) : 128 - 134
  • [47] Identification of CTNNB1 mutations, CTNNB1 amplifications, and an Axin2 splice variant in juvenile angiofibromas
    Wemmert, Silke
    Willnecker, Vivienne
    Kulas, Philipp
    Weber, Stefanie
    Lerner, Cornelia
    Berndt, Sabrina
    Wendler, Olaf
    Schick, Bernhard
    TUMOR BIOLOGY, 2016, 37 (04) : 5539 - 5549
  • [48] CTNNB1 syndrome mouse models
    Lainscek, Dusko
    Forstneric, Vida
    Mirosevic, Spela
    MAMMALIAN GENOME, 2025,
  • [49] Superficial fibromas with CTNNB1 mutation
    Kuntze, Anna
    Meliss, R. R.
    Ermert, L.
    Falkenberg, K. D.
    Puller, A. C.
    Trautmann, M.
    Hartmann, W.
    Wardelmann, E.
    GENES CHROMOSOMES & CANCER, 2024, 63 (05):
  • [50] CTNNB1 Alternation Is a Potential Biomarker for Immunotherapy Prognosis in Patients With Hepatocellular Carcinoma
    Chen, Lin
    Zhou, Qiaodan
    Liu, Junjie
    Zhang, Wei
    FRONTIERS IN IMMUNOLOGY, 2021, 12
12345